Key result
Aplastic anemia can initially present with a large inflammatory pericardial effusion driven by shared autoimmunity.
Why the study?
Pericardial effusions associated with hematologic conditions are extremely rare, and pericardial effusion as an initial presentation of aplastic anemia had not been previously documented.
Case Report (n=1)
This case report highlights that pericardial effusion can be a rare initial clinical manifestation of aplastic anemia.
Answers are grounded in this paper and cite their sources.
Alerts clinicians to rare pericardial effusion preceding aplastic anemia; hypothesis-generating case leaves association unconfirmed.
Pericardial effusion is defined as the accumulation of fluid between the visceral and parietal pericardium. The underlying etiology varies as any pathology that causes pericarditis or involves the pericardium can cause effusion. In practice, the majority of pericarditis cases are idiopathic, although these are assumed to be secondary to occult viral infection or inflammatory phenomena. Malignancy, particularly the metastatic spread of noncardiac primary tumors, has been implicated as a differential in the diagnosis of pericardial effusion. Though commonly seen in solid malignancies, effusion has been reported in hematologic malignancies such as myelodysplastic syndrome (MDS), acute leukemia, and lymphoma. Nonetheless, pericardial effusions associated with hematologic conditions are extremely rare with only one case report published describing pericardial effusion secondary to immune thrombocytopenia (ITP). We herein report the first documented case, to our knowledge, of pericardial effusion as an initial clinical manifestation of aplastic anemia in a middle-aged male presenting with pancytopenia.
No takes yet. Share an insight, caveat, or question.
Hall et al. (2023) conducted a case report in Aplastic anemia (n=1). Aplastic anemia was evaluated. Aplastic anemia can present initially with a large inflammatory pericardial effusion, likely due to a shared autoimmune phenomenon, prior to the initiation of immunosuppressive therapies.
Synapse has enriched 10 related papers. Consider them for comparative context: